Merck (MRK) Gross Margin (2009 - 2026)

Merck has disclosed Gross Margin across 18 years of filings, most recently posting 74.24% for Q1 2026.

• In Q1 2026, Gross Margin fell 374.0% year-over-year to 74.24%; the TTM figure through Mar 2026 stood at 73.91% (down 251.0% YoY), while the FY2025 annual figure was 74.8%, down 152.0% from the prior year.
• Gross Margin climbed to 74.24% in Q1 2026, from 66.15% in the prior quarter.
• Over the last five years, Gross Margin for MRK reached as high as 77.98% in Q1 2025 and fell as low as 66.15% in Q4 2025.
• The 5-year median for Gross Margin is 73.7% (2022), against an average of 73.79%.
• Annual changes were most pronounced in 2023 — Gross Margin surged 673 bps — and 2025, when it tumbled 935 bps.
• A 5-year view of Gross Margin shows it stood at 71.94% in 2022, then increased by 2 bps to 73.26% in 2023, then grew by 3 bps to 75.5% in 2024, then retreated by 12 bps to 66.15% in 2025, then climbed by 12 bps to 74.24% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 74.24%, 66.15%, and 77.69% for Q1 2026, Q4 2025, and Q3 2025 respectively.